A great number of willing patients, highly experienced researchers
and EMA-compliant legislation make the CEE region an attractive
research site destination. The data at large suggest that the high
productivity of CEE sites is accompanied by regulatory compliance
and data quality standards that are not inferior to those in Western
regions. Within this article, Jane Gelfand & Kristina Dutchack of
Adam Smith Conferences gives an overview of the key challenges
and opportunities the region presents, and analyses the latest
regulatory initiatives that are aimed at creating even more favourable
conditions for conducting clinical trials in the region.